FORNARO, MICHELE
 Distribuzione geografica
Continente #
NA - Nord America 3.009
EU - Europa 2.669
AS - Asia 2.068
AF - Africa 80
SA - Sud America 46
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 4
Totale 7.884
Nazione #
US - Stati Uniti d'America 2.954
IT - Italia 1.971
SG - Singapore 979
CN - Cina 582
VN - Vietnam 449
NL - Olanda 153
SE - Svezia 107
UA - Ucraina 87
CI - Costa d'Avorio 75
IE - Irlanda 60
CA - Canada 46
FI - Finlandia 46
DE - Germania 43
GB - Regno Unito 43
RU - Federazione Russa 41
FR - Francia 40
BR - Brasile 27
RO - Romania 12
TR - Turchia 12
ES - Italia 10
IN - India 9
AU - Australia 8
CL - Cile 8
HU - Ungheria 8
JP - Giappone 8
CH - Svizzera 7
EC - Ecuador 7
IS - Islanda 7
BG - Bulgaria 6
BE - Belgio 5
HR - Croazia 5
ID - Indonesia 5
IR - Iran 5
EU - Europa 4
MX - Messico 4
PK - Pakistan 4
PL - Polonia 4
TW - Taiwan 4
AE - Emirati Arabi Uniti 3
BZ - Belize 3
GR - Grecia 3
HK - Hong Kong 3
JO - Giordania 3
RS - Serbia 3
AR - Argentina 2
HN - Honduras 2
MA - Marocco 2
MD - Moldavia 2
PT - Portogallo 2
SK - Slovacchia (Repubblica Slovacca) 2
ZA - Sudafrica 2
EG - Egitto 1
PE - Perù 1
SA - Arabia Saudita 1
SI - Slovenia 1
SM - San Marino 1
TH - Thailandia 1
VE - Venezuela 1
Totale 7.884
Città #
Singapore 804
Dong Ket 449
Chandler 355
Millbury 340
Santa Clara 259
Princeton 224
Des Moines 203
Nanjing 201
Naples 173
Rome 150
Amsterdam 126
Milan 99
Beijing 77
Wilmington 73
Boston 69
Ashburn 64
Shenyang 62
Hebei 57
Lawrence 57
Nanchang 53
Norwalk 50
Napoli 47
Jiaxing 43
Turin 34
Ottawa 33
Casavatore 30
Tianjin 30
Houston 27
Catania 26
Redwood City 23
Bari 22
Genoa 22
Livorno 20
Florence 18
Changsha 17
Dublin 17
Jacksonville 15
Trieste 14
Cagliari 13
The Dalles 13
Woodbridge 12
Bologna 11
Buffalo 11
Fairfield 11
Padova 11
Seattle 11
Torino 11
Castelnuovo Rangone 9
Helsinki 9
Kronberg 9
Timisoara 9
Boardman 8
Lappeenranta 8
Sezze 8
Urbino 8
Ann Arbor 7
Frankfurt am Main 7
Palermo 7
Parma 7
Pescara 7
Reykjavík 7
Salerno 7
Scarperia 7
Atlanta 6
Brescia 6
Casoria 6
Città di Castello 6
Kayseri 6
Loja 6
Monza 6
Paris 6
Perugia 6
Portici 6
Sassari 6
Sofia 6
West Jordan 6
Bollate 5
Brooklyn 5
Caivano 5
Novara 5
Quartu Sant'Elena 5
Radda in Chianti 5
Rho 5
Riccione 5
Shenzhen 5
São Paulo 5
Toronto 5
Treviso 5
Viareggio 5
Viterbo 5
Alghero 4
Andover 4
Arzano 4
Aversa 4
Capaccio 4
Catanzaro 4
Cava de' Tirreni 4
Council Bluffs 4
Elmas 4
Formia 4
Totale 4.799
Nome #
Disturbo bipolare e malattie disreattive: una relazione complessa 707
Disturbo borderline e spettro bipolare: una ricerca epidemiologica 232
Comorbidità tra Disturbo da Deficit dell'Attenzione e Iperattività nell'adulto e Distubo Bipolare - prevalenza e caratteristiche cliniche in uno studio preliminare 138
Valutazione elettroretinografica (ERG) in pazienti con depressione maggiore in trattamento con duloxetina: differenza tra “responders” e “non-responders” quale possibile indice di un pattern biologico differenziale. 118
“XLIV Congresso Nazionale della Società Italiana di Psichiatria (SIP) 2006”. Palacongressi d’Abruzzo, Montesilvano (Pescara) 15-20 ottobre 2006. (simposio dal titolo “L’identità dello Psichiatra: le opinioni degli specializzandi in Psichiatria italiani” – abstract book pp.247. 107
Miglioramento clinico con bupropione della Sindrome delle Gambe Senza Riposo indotto dal trattamento con mirtazapna e duloxetina in un paziente affetto da Depressione Maggiore 88
Psychological distress in serious mental illness patients during the COVID-19 outbreak and one-month mass quarantine in Italy 65
Current and future perspectives on the Major Depressive Disorder: Focus on the new multimodal antidepressant Vortioxetine 63
Obsessive-Compulsive Aspects and Pathological Gambling in an Italian Sample 60
Factor structure and reliability of the Italian adaptation of the Hypomania Check List-32, second revision (HCL-32-R2). 59
Prevalence and correlates of major depressive disorder, bipolar disorder and schizophrenia among nursing home residents without dementia: systematic review and meta-analysis 58
Associate Editor 57
Studio dell'Asse Ipotalamo-Ipofisi-Surrene nei pazienti con Depressione Maggiore prima e dopo trattamento con Reboxetina 55
Impulsività e disturbi d’ansia: il ruolo della ciclotimia 53
Efficacia e sicurezza dell’asenapina in pazienti con episodi maniacali e misti associati a disturbo bipolare I 48
Adjunctive agomelatine therapy in the treatment of acute bipolar II depression: a preliminary open label study 47
Treatment-Resistant to Antipsychotics: A Resistance to Everything? Psychotherapy in Treatment-Resistant Schizophrenia and Nonaffective Psychosis: A 25-Year Systematic Review and Exploratory Meta-Analysis 45
The Relationships between Cholesterol and Suicide: An Update 43
Agomelatine beyond borders: current evidences of its efficacy in disorders other than major depression 42
May second generation long-acting injectable antipsychotics be prescribed as a first-line treatment of first episode in patients with schizophrenia? An overview. 42
Impulsività e disturbi d’ansia: uno studio caso-controllo 42
“Duloxetina e Bupropione in Medicina Generale” Aggiornamento ECM per Medici di Medicina Generale. Centro Ricerca G. De Lisio (Coordinatore Scientifico, Prof. G. Perugi), Pisa 15-12-2008. 40
Preclinical considerations about affective disorders and pain: A broadly intertwined, yet often under-explored, relationship having major clinical implications 40
New advances in the treatment of generalized anxiety disorder: The multimodal antidepressant vortioxetine 39
The role of melatonin in mood disorders 39
Incidence, prevalence and clinical correlates of antidepressant-emergent mania in bipolar depression: a systematic review and meta-analysis 39
Affective temperaments are associated with specific clusters of symptoms and psychopathology: A cross-sectional study on bipolar disorder inpatients in acute manic, mixed, or depressive relapse. 38
Agomelatine in the treatment of panic disorder 38
C-reactive protein level and its relationship with suicide risk and alexithymia among newly diagnosed, drug-naïve patients with non-affective psychosis 37
Effect of agomelatine treatment on C-reactive protein levels in patients with major depressive disorder: an exploratory study in “real-world,” everyday clinical practice 37
Predictors of hospitalization length of stay among re-admitted treatment-resistant Bipolar Disorder inpatients 37
Treating the Synapse in Major Psychiatric Disorders: The Role of Postsynaptic Density Network in Dopamine-Glutamate Interplay and Psychopharmacologic Drugs Molecular Actions 37
Are atypical depression, borderline personality disorder and bipolar II disorder overlapping manifestations of a common cyclothymic diathesis? 37
Celiac disease and ADHD: mini-review and critique 37
"Aspetti etologici e terapeutici della comorbilità tra Depressione e Disturbo Post-Traumatico da Stress" 37
Adding 5-hydroxytryptamine receptor type 3 antagonists may reduce drug-induced nausea in poor insight obsessive-compulsive patients taking off-label doses of selective serotonin reuptake inhibitors: a 52-week follow-up case report 37
Adjunctive vortioxetine for SSRI-resistant major depressive disorder: a "real-world" chart review study 37
Electroretinographic modifications induced by agomelatine: a novel avenue to the understanding of the claimed antidepressant effect of the drug? 36
Adjunctive agomelatine therapy in the treatment of acute bi¬polar II depression: a preliminary open label study (MONOGRAFIA segnalata dalla International Society for Bipolar Disorder - ISBD) 36
Psychological perspective of medication adherence in transplantation 36
Alexithymia and Suicide Risk in Psychiatric Disorders: A Mini-Review 36
Clinical and psychopathological features associated with treatment-emergent mania in bipolar-II depressed outpatients exposed to antidepressants 35
Agomelatine treatment of major depressive disorder in Parkinson's disease: a case series 35
“Continuum Ansia e Depressione”. Presentazione casi clinici. (Boehringer-Ingelheim). Camogli (Genova), 17-18 aprile 2009 (co-relatori: G. Biggio, G. Cerveri, C. Mencacci, G.R. Perna, R.L. Picci, V. Rosso, R. Torta, M. Vaggi). 34
Academic Editor 34
Somatopsychic correlates and quality of life of the dialyzed patient: a cross-sectional study 34
A comparative meta-analysis of TEMPS scores across mood disorder patients, their first-degree relatives, healthy controls, and other psychiatric disorders 34
Eradicating suicide at its roots: Preclinical bases and clinical evidence of the efficacy of ketamine in the treatment of suicidal behaviors 34
Cariprazine (RGH-188): A new pharmacological target option for the treatment of schizophrenia, bipolar disorders and depression? 33
Alexithymia and Breast Cancer Surgery: A Systematic Review 33
VEGF plasma level variations in duloxetine-treated patients with major depression 33
Targeting the Noradrenergic System in Posttraumatic Stress Disorder: A Systematic Review and Meta-Analysis of Prazosin Trials 32
Lurasidone in the Treatment of Bipolar Depression: Systematic Review of Systematic Reviews 32
Tinnitus psychopharmacology: A comprehensive review of its pathomechanisms and management 32
Progress in bipolar disorder drug design toward the development of novel therapeutic targets: a clinician's perspective 32
The identification of biomarkers predicting acute and maintenance lithium treatment response in bipolar disorder: A plea for further research attention 32
An Update on Glutamatergic System in Suicidal Depression and on the role of Esketamine 32
Alexithymia, resilience, somatic sensations and their relationships with suicide ideation in drug naïve patients with first-episode major depression: An exploratory study in the “real world” everyday clinical practice 32
"Novel Psychopharmacology for Depressive Disorders" 32
Incidence, prevalence, and global burden of schizophrenia - data, with critical appraisal, from the Global Burden of Disease (GBD) 2019 31
Alexithymia, Suicide Ideation, C-Reactive Protein, and Serum Lipid Levels Among Outpatients with Generalized Anxiety Disorder 31
Prevalence and clinical features associated with bipolar disorder polypharmacy: a systematic review 31
Different measures of impulsivity in patients with anxiety disorders: a case control study 31
Discriminative hypomania checklist-32 factors in unipolar and bipolar major depressive patients 31
The burden of mood-disorder/cerebrovascular disease comorbidity: essential neurobiology, psychopharmacology, and physical activity interventions 31
Treatment of antipsychotic-induced hyperprolactinemia: an update on the role of the dopaminergic receptors D2 partial agonist aripiprazole 30
Aderenza al trattamento in pazienti bipolari tipo-II in fase acuta depressiva: correlati psicopatologici del temperamento ciclotimico e “therapeutic sensation seeking” in risposta alla incapacità di sopportazione del dolore soggettivo 30
Clozapine-related Sudden Pericarditis in a Patient Taking Long Acting Aripiprazole and Valproate: A Case Report 30
The ‘dead man walking’ disorder: an update on Cotard’s syndrome 30
Aripiprazole for relapse prevention and craving in alcohol use disorder: Current evidence and future perspectives 29
Impulsività e disturbo da panico: il ruolo della ciclotimia 29
Adherence to Chronic Therapies in Psychiatry: From Treatment to Cure.The Relevance of Therapeutic Relationship 29
Cotard’s Syndrome: Clinical Case Presentation and Literature Review 29
Aspirin and incident depressive symptoms: A longitudinal cohort study over 8 years 29
The argument of antidepressant drugs in the treatment of bipolar depression: mixed evidence or mixed states? 29
Sensation seeking in major depressive patients: relationship to sub-threshold bipolarity and cyclothymic temperament 29
“Agomelatina – Innovazione nel trattamento della depressione maggiore” (Servier). Genova 28 ottobre 2010, co-relatori, Prof. Popoli, Prof. L. Ferrannini, Dr. M. Vaggi. 29
Cotard's Syndrome after breast surgery successfully treated with aripiprazole augmentation of escitalopram: a case report 28
Effetti oftalmologici indesiderati dei farmaci antidepressivi, ansiolitici e stabilizzatori del tono dell'umore 28
EU-Finder “Factors Influencing Depression Endpoints Research” (studio osservazionale su pazienti in trattamento per Episodio Depressivo Maggiore in atto); anno 2004-2005.. 28
“Resistenza alla gestione farmacologica della depressione bipolare resistente: Refrattarietà vs. tolleranza a litio in pazienti precedentemente responsivi. Inquadramento clinico, cenni neurobiologici, e prospettive terapeutiche.” – Evento: “Unveiling the dark side of the mood: nuove prospettive diagnostiche e terapeutiche per il trattamento dei disturbi depressivi”. Giulianova (Teramo), 6 Ottobre 2016. 28
The emergence of loss of efficacy during antidepressant drug treatment for major depressive disorder: An integrative review of evidence, mechanisms, and clinical implications 28
Prominent autistic traits and subthreshold bipolar/mixed features of depression in severe anorexia nervosa 28
The effects of sustained COVID-19 emergency and restrictions on the mental health of subjects with serious mental illness: A prospective study 27
Efficacy and safety of long acting injectable atypical antipsychotics: a review 27
A comprehensive review on the efficacy of S-Adenosyl-L-methionine in Major Depressive Disorder 27
Alexithymia, responsibility attitudes and suicide ideation among outpatients with obsessive-compulsive disorder: An exploratory study 27
Alexithymia and its relationships with acute phase proteins and cytokine release: an updated review 27
Effetti collaterali oftalmologici dei farmaci antipsicotici 27
Prevalence and diagnostic distribution of medically unexplained painful somatic symptoms across 571 major depressed outpatients 27
Obsessive-compulsive disorder with bipolar diathesis following isotretinoin therapy remitting upon treatment with olanzapine and fluvoxamine 27
The influence of affective temperaments and psychopathological traits on the definition of bipolar disorder subtypes: a study on bipolar I Italian national sample 27
Agomelatine reversal of escitalopram-induced apathy: a case report 27
Psychopathological aspects of kidney transplantation: Efficacy of a multidisciplinary team 27
The relationship between drive to thinness, conscientiousness and bulimic traits during adolescence: a comparison between younger and older cases in 608 healthy volunteers 27
An open pilot study of zonisamide augmentation in major depressive patients not responding to a low dose trial with duloxetine: preliminary results on tolerability and clinical effects 27
Electroretinographic assessment in major depressed patients receiving duloxetine: might differences between responders and non-responders indicate a differential biological background? 27
Predictors of Treatment Resistance Across Different Clinical Subtypes of Depression: Comparison of Unipolar vs. Bipolar Cases 27
Is there a biosignature for lithium response in bipolar disorder? Evidence and implications 27
The Novel Antipsychotic Cariprazine (RGH-188): State-of-the-Art in the Treatment of Psychiatric Disorders 26
Totale 4.678
Categoria #
all - tutte 39.322
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.322


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020222 0 0 0 0 0 19 5 4 8 112 58 16
2020/2021917 24 37 39 36 28 104 53 25 45 27 31 468
2021/20221.407 83 14 33 57 30 94 51 67 93 102 147 636
2022/20231.378 306 98 47 59 113 139 36 89 191 145 102 53
2023/20241.604 71 168 145 115 80 59 139 182 73 105 287 180
2024/20251.723 523 744 66 106 277 7 0 0 0 0 0 0
Totale 8.424